Pap in the City: a journey to co-testing for HPV in Hong Kong

A.ChengA.Cheng
BulletArticle
RED 2019 Cervical Cancer Molecular Diagnostics Oncology Women's Health
Bagikan:
Salin tautan
Anita_cheng_2

The Teal project brought together the Roche Team, Christian Action, University of Hong Kong, Karen Leung Foundation and Central Health to offer Co-testing for HPV to hundreds of under privileged women in the busy city of Hong Kong. Their efforts constituted a fight against one of the most common but preventable cancers affecting women.

Bagikan:
Salin tautan

Lainnya dalam topik yang sama

Time to review the gold standard for cervical cancer screening

How to implement HPV DNA testing as a primary screening tool?

Rekomendasi topik

SequencingRED 2020Rare Diseases
Bacaan Berikutnya
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top